Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $1.63 on 17-10-2025 at 18:50:08
Change $0.00 0%
Buy $1.62
Sell $1.585
Last Trade: Buy 188,359.00 at $1.63
Day's Volume: 367,160
Last Close: $1.63
Open: $1.62
ISIN: GG00BKTRRM22
Day's Range $1.585 - $1.63
52wk Range: $1.08 - $1.63
Market Capitalisation: $533.54m
VWAP: $1.614568
Shares in Issue: 327.32m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 188,359 $1.63 Suspected BUY Trade
16:35:24 - 17-Oct-25
Sell* 5 $1.60 SI Trade
15:41:34 - 17-Oct-25
Buy* 334 $1.615 Automatic Execution
15:41:34 - 17-Oct-25
Buy* 2,103 $1.605 Automatic Execution
15:11:16 - 17-Oct-25
Unknown* 636 $1.605 OTC Trade
15:05:00 - 17-Oct-25
Buy* 1 $1.605 SI Trade
15:01:53 - 17-Oct-25
Buy* 119 $1.605 Automatic Execution
14:57:04 - 17-Oct-25
Buy* 9,403 $1.60 Automatic Execution
14:57:01 - 17-Oct-25
Buy* 20 $1.60 SI Trade
14:39:10 - 17-Oct-25
Buy* 10 $1.60 Automatic Execution
14:39:10 - 17-Oct-25
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Oct 2025 (Fri) 1.62 1.63 1.585 1.63 367,160
16th Oct 2025 (Thu) 1.62 1.63 1.605 1.63 205,549
15th Oct 2025 (Wed) 1.605 1.62 1.585 1.62 245,193
14th Oct 2025 (Tue) 1.605 1.605 1.585 1.59 220,596
13th Oct 2025 (Mon) 1.62 1.62 1.595 1.61 178,217
10th Oct 2025 (Fri) 1.595 1.61 1.59 1.595 3,143,717
9th Oct 2025 (Thu) 1.57 1.59 1.55 1.59 1,987,758
8th Oct 2025 (Wed) 1.545 1.57 1.545 1.555 1,404,338
7th Oct 2025 (Tue) 1.56 1.56 1.55 1.55 2,246,433
6th Oct 2025 (Mon) 1.555 1.555 1.55 1.555 852,752
3rd Oct 2025 (Fri) 1.55 1.555 1.55 1.55 356,735
2nd Oct 2025 (Thu) 1.55 1.555 1.545 1.55 462,085
1st Oct 2025 (Wed) 1.54 1.55 1.53 1.545 4,012,932
30th Sep 2025 (Tue) 1.53 1.545 1.51 1.54 3,007,665
29th Sep 2025 (Mon) 1.52 1.53 1.515 1.52 1,477,125
26th Sep 2025 (Fri) 1.52 1.53 1.51 1.52 922,692
25th Sep 2025 (Thu) 1.54 1.55 1.52 1.52 1,293,538
24th Sep 2025 (Wed) 1.50 1.535 1.49 1.53 5,207,468
23rd Sep 2025 (Tue) 1.47 1.50 1.47 1.495 1,435,491
22nd Sep 2025 (Mon) 1.49 1.49 1.46 1.48 909,736
19th Sep 2025 (Fri) 1.495 1.505 1.485 1.485 9,342,868
18th Sep 2025 (Thu) 1.505 1.505 1.47 1.49 901,563
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
15th Oct 2025 7:00 am RNS Kailera Therapeutics announces Series B financing
14th Oct 2025 7:00 am RNS Monthly Valuation Update and Factsheet
10th Oct 2025 7:00 am RNS Novo Nordisk to acquire Akero Therapeutics
1st Oct 2025 7:00 am RNS Total Voting Rights
30th Sep 2025 7:01 am RNS Transaction in Own Shares
30th Sep 2025 7:00 am RNS Genmab to acquire Merus
29th Sep 2025 7:00 am RNS Transaction in Own Shares
26th Sep 2025 7:00 am RNS Transaction in Own Shares
25th Sep 2025 7:00 am RNS Transaction in Own Shares
24th Sep 2025 7:00 am RNS Transaction in Own Shares
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

RTW Biotech invests USD7.4 million in financing round for Kailera

15th Oct 2025 13:17

(Alliance News) - RTW Biotech Opportunities Ltd said on Wednesday that it invested USD7.4 million in Kailera Therapeutics Inc for the company's USD600 million Series B financing round. Read More

Akero says new owner Novo Nordisk to drive commercialisation process

10th Oct 2025 11:58

(Alliance News) - Akero Therapeutics Inc on Friday said it will benefit from "industry-leading development capabilities and commercial infrastructure" through its acquisition by Novo Nordisk AS. Read More

IN BRIEF: RTW Biotech lifts NAV on Biogen's USD85 million Alcyone deal

23rd Sep 2025 11:01

RTW Biotech Opportunities Ltd - Guernsey, Channel Islands-based investor in high-growth life science sectors - Notes Biogen Inc's agreement announced last Thursday to acquire portfolio company Alcyone Therapeutics Inc for USD85 million upfront plus milestone payments. Says the deal represents a 242% uplift on RTW's USD2.1 million carrying value of Alcyone, adding USD5.0 million, or around 0.7%, to its August 31 NAV, where Alcyone represented approximately a 0.3% position. Alcyone is developing ThecaFlex DRx, an implantable device for intrathecal delivery of neurological therapies, which Biogen plans to deploy with its marketed drug Spinraza, with a launch targeted in 2028. The transaction its RTW's second portfolio takeout this year, following Merck & Co Inc's purchase of Verona Pharma PLC, and says it highlights embedded value in its private holdings. Read More

RTW Biotech Opportunities NAV falls in "volatile" period for biotech

11th Sep 2025 10:29

(Alliance News) - RTW Biotech Opportunities Ltd on Thursday said the biotech industry is navigating a "complex but increasingly constructive environment" as it reported a decline in its interim net asset value per share. Read More

IN BRIEF: RTW Biotech Opportunities joins FTSE all-share index

5th Sep 2025 09:27

RTW Biotech Opportunities Ltd - Guernsey, Channel Islands-based investor in high-growth life science sectors - Says it will join the FTSE all-share index on September 22. This follows FTSE Russell's decision to include securities trading in non-sterling currencies. Chair William Simpson says the move "is likely to enhance our exposure to investors, develop greater UK and international investor awareness of RTW Bio, and provide increased long-term access to capital." Read More

See more Rtw Biotech news
FTSE 100 Latest
Value9,354.57
Change-81.52

Login to your account

Forgot Password?

Not Registered